A plaintiff and his wife have filed a Byetta cancer lawsuit in California, claiming long time use of the drug to treat type II diabetes led to a thyroid cancer diagnosis. This complaint joins a growing number of Byetta & Januvia lawsuits in coordinated proceedings in the U.S. District Court... Read more »

The drug Januvia is a widely-popular diabetes treatment option known as an “incretin mimetic.” The drug is manufactured by pharmaceutical giant Merck Sharp & Dohme, Corp. (hereinafter, “Merck”) and is one of the top-selling diabetes medications to date. However, an increasing number of Januvia users are reporting the sudden and... Read more »

Dara Goldstein, individually and as successor in interest of the estate of Samuel Goldstein, has submitted a short form complaint for monetary damages against Merck, Sharpe & Dohme. The plaintiff claims that her now deceased husband developed pancreatic cancer and subsequently died as a direct result of taking the diabetes... Read more »